2018
DOI: 10.1016/j.phoj.2018.06.002
|View full text |Cite
|
Sign up to set email alerts
|

Emergency management of SCD pain crises: Current practices and playing variables

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 7 publications
2
5
0
Order By: Relevance
“…This means that there was a delay in relieving pain which compromised the quality of life in these children. These ndings are consistent with (42) who found that patients with SCD experienced signi cant delays in seeking medication on pain relief. Unrelieved pain may prolong the stress response and adversely affect the recovery process (43).…”
Section: Discussionsupporting
confidence: 91%
“…This means that there was a delay in relieving pain which compromised the quality of life in these children. These ndings are consistent with (42) who found that patients with SCD experienced signi cant delays in seeking medication on pain relief. Unrelieved pain may prolong the stress response and adversely affect the recovery process (43).…”
Section: Discussionsupporting
confidence: 91%
“…This often leads to mistrust between patients and health care providers [36,37]. As several studies demonstrated [38][39][40][41][42][43][44], when patients arrive in emergency departments, the lack of objective hematological findings and little awareness of those findings make health care providers suspicious of the veracity of a VOC. This distrust makes the SCD community infamously difficult to recruit in research initiatives and hard to engage in interactions with medical providers, and the distrust also lowers adherence to medical recommendations [36,[45][46][47][48].…”
Section: The Case Of Sickle Cell Disease: One Of the World's Most Neg...mentioning
confidence: 99%
“…The gene frequency of SCD is highest in West African countries, with 25-30% of people being carriers of HbS compared to 1 in 400 African Americans, and it is variable in European populations [6]. Severe morbidity and mortality ensue when SCD is not diagnosed and treated promptly [7]. In Nigeria, the overall prevalence of the 2 common variances of SCD are HbSS (2.14%) and HbSC (0.14%) [8].…”
Section: Introductionmentioning
confidence: 99%